BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25938168)

  • 1. Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?
    Yarman S; Ogret YD; Oguz FS
    Genet Test Mol Biomarkers; 2015 Jul; 19(7):394-8. PubMed ID: 25938168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of
    Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
    Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
    [No Abstract]   [Full Text] [Related]  

  • 3. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
    Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should aip gene screening be recommended in family members of FIPA patients with R16H variant?
    Zatelli MC; Torre ML; Rossi R; Ragonese M; Trimarchi F; degli Uberti E; Cannavò S
    Pituitary; 2013 Jun; 16(2):238-44. PubMed ID: 22915287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Daly AF; Beckers A
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):19-25. PubMed ID: 25732638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
    Daly AF; Vanbellinghen JF; Khoo SK; Jaffrain-Rea ML; Naves LA; Guitelman MA; Murat A; Emy P; Gimenez-Roqueplo AP; Tamburrano G; Raverot G; Barlier A; De Herder W; Penfornis A; Ciccarelli E; Estour B; Lecomte P; Gatta B; Chabre O; Sabaté MI; Bertagna X; Garcia Basavilbaso N; Stalldecker G; Colao A; Ferolla P; Wémeau JL; Caron P; Sadoul JL; Oneto A; Archambeaud F; Calender A; Sinilnikova O; Montañana CF; Cavagnini F; Hana V; Solano A; Delettieres D; Luccio-Camelo DC; Basso A; Rohmer V; Brue T; Bours V; Teh BT; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1891-6. PubMed ID: 17244780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation.
    Villa C; Lagonigro MS; Magri F; Koziak M; Jaffrain-Rea ML; Brauner R; Bouligand J; Junier MP; Di Rocco F; Sainte-Rose C; Beckers A; Roux FX; Daly AF; Chiovato L
    Endocr Relat Cancer; 2011 Jun; 18(3):347-56. PubMed ID: 21450940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
    Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis.
    Cai F; Zhang YD; Zhao X; Yang YK; Ma SH; Dai CX; Liu XH; Yao Y; Feng M; Wei JJ; Xing B; Jiao YH; Wei ZQ; Yin ZM; Zhang B; Gu F; Wang RZ
    Eur J Endocrinol; 2013 Dec; 169(6):867-84. PubMed ID: 24050928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
    Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Beckers A; Aaltonen LA; Daly AF; Karhu A
    Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
    Beckers A; Daly AF
    Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
    Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML
    Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature].
    Fajardo-Montañana C; Daly AF; Riesgo-Suárez P; Gómez-Vela J; Tichomirowa MA; Camara-Gómez R; Beckers A
    Endocrinol Nutr; 2009; 56(7):369-77. PubMed ID: 19883897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
    Barlier A; Vanbellinghen JF; Daly AF; Silvy M; Jaffrain-Rea ML; Trouillas J; Tamagno G; Cazabat L; Bours V; Brue T; Enjalbert A; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1952-5. PubMed ID: 17299063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion.
    Cai F; Hong Y; Xu J; Wu Q; Reis C; Yan W; Wang W; Zhang J
    World Neurosurg; 2019 Mar; 123():e45-e59. PubMed ID: 30447469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIP mutations and gigantism.
    Rostomyan L; Potorac I; Beckers P; Daly AF; Beckers A
    Ann Endocrinol (Paris); 2017 Jun; 78(2):123-130. PubMed ID: 28483363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA).
    Vasilev V; Daly AF; Trivellin G; Stratakis CA; Zacharieva S; Beckers A
    Endocr Relat Cancer; 2020 Aug; 27(8):T77-T86. PubMed ID: 32083999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas.
    Buchbinder S; Bierhaus A; Zorn M; Nawroth PP; Humpert P; Schilling T
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):625-8. PubMed ID: 18484068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.